Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion type Assertion NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_head.
- NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion wasGeneratedBy ECO_0000203 NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_provenance.
- NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion wasDerivedFrom befree-20140225 NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_provenance.
- NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion SIO_000772 19638963 NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_provenance.
- NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion evidence source_evidence_literature NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_provenance.
- NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_assertion description "[Aneuploidy (HR 3.5; 95% CI: 1.3-9.4), strong Ki67 overexpression (HR 5.2; 95% CI: 1.5-17.6), and moderate p53 overexpression (HR 6.5; 95% CI: 2.5-17.1) were also associated with an increased risk of developing HGD/EAC, independent of the histological result.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692577.RArG37em6816lR6DDdUuprz7cy6tTpO1RoeCS7nxZDEXM130_provenance.